After you submit your request, a staff member will contact you.There’s no obligation and our team is here to help you decide on a study that’s best for you.
A Phase II Randomised, Doubleblind, Placebo-controlled study to evaluate the efficacy, safety and tolerability of AZD6234 in participants living with overweight or obesity with Type 2 Diabetes who are on a stable dose of GLP-1 Receptor Agonist